News

FreeOx Biotech is licensed for the new neuroprotective molecule Ox-02

FreeOx Biotech has signed an exclusive licence agreement to develop and exploit the product patent of the molecule Ox-02 with the 

Read More

Dos científics de l'IIBB entre el 2% a nivell mundial com a científics més influents segons la Universitat de Stanford.

Researchers from Stanford University (California, United States) have recently published the “Ranking of the World Scientists: World's Top 2% Scientists”, which identifies the most influential rese

Read More

The Science Week 2021 recorded lectures of are now available

Science Week 2021 at the Barcelona Institute for Biomedical Research (IIBB-CSIC) has ended successfully.

Read More

1st CIBEREHD Research School on November 26 and 27

The CIBER of Liver and Digestive Diseases (CIBEREHD) will be celebrating the 26 and 27 of November, the first edition of its Research School, an innovative activity for scientific training that aim

Read More

LIVER CANCER: RESEARCH AND PREVENTION

Read More

The ins and outs of Parkinson’s disease

On November 2 it will take place at the Edifici Transfronterer, on the Campus of Cappont Universitat de Lleida. The event will begin at 4:00 p.m. and will last until 6:00 p.m.

Read More

Researchers from the IIBB-CSIC participate in a study that shows the interaction of the receptor for cannabinoids with the BiP protein in terminals of inhibitory neurons, modulating anxiety.

The study shows that the cannabinoid receptor CB1 (CB1R), the main molecular target of the bioactive components of cannabis, specifically interacts with an intracellular protein called BiP.

Read More

Pages